AdAlta Ltd Sustainability Reports
AdAlta Limited is a clinical-stage biotechnology company that discovers and develops next-generation protein and cell-based therapeutics. It utilizes its proprietary i-body technology platform to generate unique compounds for treating challenging drug targets, with a primary focus on fibrotic diseases and cellular immunotherapies for solid cancers.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 254900XT3BQIT6GR6M94
FIGI: BBG00D9SX1N6
7 reports from 2016 to 2024
